The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Eisai; Janssen Research & Development
Travel, Accommodations, Expenses - Janssen-Cilag
Abiraterone acetate plus prednisone (AA+P) without continuing LHRH-therapy in patients with metastatic chemotherapy: Naive castrations-resistant prostate cancer—Results from the SPARE-trial (NCT02077634).
 
Carsten Henning Ohlmann
Consulting or Advisory Role - Janssen-Cilag
Speakers' Bureau - Janssen-Cilag
Research Funding - Janssen-Cilag
 
Christoph Ruessel
No Relationships to Disclose
 
Roger Zillmann
No Relationships to Disclose
 
Eva Hellmis
No Relationships to Disclose
 
Henrik Suttmann
No Relationships to Disclose
 
Martin Janssen
No Relationships to Disclose
 
Jan Marin
No Relationships to Disclose
 
Johannes Dahm
No Relationships to Disclose
 
Andreas Hübner
No Relationships to Disclose
 
Jochen Gleissner
No Relationships to Disclose
 
Michael Scheffler
No Relationships to Disclose
 
Susan Feyerabend
No Relationships to Disclose
 
Jens Telle
No Relationships to Disclose
 
Peter Jähnig
No Relationships to Disclose
 
Michelle Jäschke
No Relationships to Disclose
 
Joerg Klier
No Relationships to Disclose